HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Could Unilever Investment In Microalgae Solve Firm's Palm Oil Problems?

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

Unilever is reasserting its commitment to environmental sustainability with an undisclosed investment in Solazyme, the same company that is helping the U.S. Navy to reach its renewable fuel goals

You may also be interested in...



In Brief

IFRA Investigates Banned Ingredient Use

In Brief

IFRA Investigates Banned Ingredient Use

In Brief

Council Video Squashes Cosmetic Rumors

Table

View full table

Related Content

HBW Insight
HBW Insight
Tags:
Latest Headlines

Prestige Expands UK Eye Care Range In Response To Consumer Demand

Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation

Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD

Marinomed Takes Virus-Blocking Device Into Allergy And Dry Eye Categories

See All
UsernamePublicRestriction

Register

RS017196

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By